IDENTIV INC (INVE) Fundamental Analysis & Valuation

NASDAQ:INVE • US45170X2053

3.3 USD
+0.09 (+2.8%)
Last: Mar 4, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This INVE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Overall INVE gets a fundamental rating of 4 out of 10. We evaluated INVE against 124 industry peers in the Electronic Equipment, Instruments & Components industry. While INVE has a great health rating, there are worries on its profitability. While showing a medium growth rate, INVE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. INVE Profitability Analysis

1.1 Basic Checks

  • In the past year INVE has reported negative net income.
  • In the past year INVE has reported a negative cash flow from operations.
  • In multiple years INVE reported negative net income over the last 5 years.
  • In multiple years INVE reported negative operating cash flow during the last 5 years.
INVE Yearly Net Income VS EBIT VS OCF VS FCFINVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

  • INVE has a worse Return On Assets (-10.23%) than 62.10% of its industry peers.
  • The Return On Equity of INVE (-10.76%) is worse than 61.29% of its industry peers.
Industry RankSector Rank
ROA -10.23%
ROE -10.76%
ROIC N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
INVE Yearly ROA, ROE, ROICINVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • In the last couple of years the Profit Margin of INVE has grown nicely.
  • INVE does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
INVE Yearly Profit, Operating, Gross MarginsINVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 200

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INVE Health Analysis

2.1 Basic Checks

  • INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, INVE has more shares outstanding
  • The number of shares outstanding for INVE has been increased compared to 5 years ago.
  • INVE has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
INVE Yearly Shares OutstandingINVE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
INVE Yearly Total Debt VS Total AssetsINVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • INVE has an Altman-Z score of 3.84. This indicates that INVE is financially healthy and has little risk of bankruptcy at the moment.
  • INVE has a Altman-Z score of 3.84. This is in the better half of the industry: INVE outperforms 63.71% of its industry peers.
  • There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.84
ROIC/WACCN/A
WACC8.97%
INVE Yearly LT Debt VS Equity VS FCFINVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 21.08 indicates that INVE has no problem at all paying its short term obligations.
  • INVE's Current ratio of 21.08 is amongst the best of the industry. INVE outperforms 96.77% of its industry peers.
  • INVE has a Quick Ratio of 20.20. This indicates that INVE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 20.20, INVE belongs to the best of the industry, outperforming 97.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 21.08
Quick Ratio 20.2
INVE Yearly Current Assets VS Current LiabilitesINVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. INVE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 16.67% over the past year.
  • INVE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 438.90% yearly.
  • Looking at the last year, INVE shows a very negative growth in Revenue. The Revenue has decreased by -54.99% in the last year.
  • Measured over the past years, INVE shows a very negative growth in Revenue. The Revenue has been decreasing by -20.49% on average per year.
EPS 1Y (TTM)16.67%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)-54.99%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-23.32%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.00% on average over the next years. This is quite good.
  • INVE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.86% yearly.
EPS Next Y23.34%
EPS Next 2Y16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-56.13%
Revenue Next 2Y-29.96%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INVE Yearly Revenue VS EstimatesINVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 50M 100M
INVE Yearly EPS VS EstimatesINVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

0

4. INVE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for INVE. In the last year negative earnings were reported.
  • Also next year INVE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
INVE Price Earnings VS Forward Price EarningsINVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
INVE Per share dataINVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • A more expensive valuation may be justified as INVE's earnings are expected to grow with 16.00% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVE Dividend Analysis

5.1 Amount

  • INVE does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVE Fundamentals: All Metrics, Ratios and Statistics

IDENTIV INC

NASDAQ:INVE (3/4/2026, 8:00:03 PM)

3.3

+0.09 (+2.8%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)11-10
Earnings (Next)03-12
Inst Owners53.66%
Inst Owner Change5.98%
Ins Owners0.81%
Ins Owner Change-0.02%
Market Cap78.38M
Revenue(TTM)22.02M
Net Income(TTM)-15.46M
Analysts82.22
Price Target5.44 (64.85%)
Short Float %1.17%
Short Ratio8.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.4%
Min EPS beat(2)-3.34%
Max EPS beat(2)32.13%
EPS beat(4)3
Avg EPS beat(4)20.36%
Min EPS beat(4)-3.34%
Max EPS beat(4)38.44%
EPS beat(8)3
Avg EPS beat(8)-23.62%
EPS beat(12)5
Avg EPS beat(12)-28%
EPS beat(16)7
Avg EPS beat(16)-49.99%
Revenue beat(2)0
Avg Revenue beat(2)-2.45%
Min Revenue beat(2)-3.11%
Max Revenue beat(2)-1.78%
Revenue beat(4)2
Avg Revenue beat(4)1.7%
Min Revenue beat(4)-3.11%
Max Revenue beat(4)7.34%
Revenue beat(8)3
Avg Revenue beat(8)0.55%
Revenue beat(12)3
Avg Revenue beat(12)-1.16%
Revenue beat(16)4
Avg Revenue beat(16)-2.1%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)12.28%
EPS NY rev (1m)0%
EPS NY rev (3m)12.13%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.56
P/FCF N/A
P/OCF N/A
P/B 0.55
P/tB 0.55
EV/EBITDA N/A
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-0.72
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0.93
BVpS6.05
TBVpS6.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.23%
ROE -10.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)12.53%
ROA(5y)6.04%
ROE(3y)12.26%
ROE(5y)3.86%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y732.24%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 69.13%
Cap/Sales 6.93%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 21.08
Quick Ratio 20.2
Altman-Z 3.84
F-Score2
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)126.88%
Cap/Depr(5y)106.77%
Cap/Sales(3y)6.31%
Cap/Sales(5y)4.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.67%
EPS 3Y438.9%
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y23.34%
EPS Next 2Y16%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-54.99%
Revenue growth 3Y-36.46%
Revenue growth 5Y-20.49%
Sales Q2Q%-23.32%
Revenue Next Year-56.13%
Revenue Next 2Y-29.96%
Revenue Next 3Y40.96%
Revenue Next 5Y30.86%
EBIT growth 1Y0.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year22.92%
EBIT Next 3Y45.38%
EBIT Next 5Y33.76%
FCF growth 1Y-38.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-86.11%
OCF growth 3YN/A
OCF growth 5YN/A

IDENTIV INC / INVE FAQ

Can you provide the ChartMill fundamental rating for IDENTIV INC?

ChartMill assigns a fundamental rating of 4 / 10 to INVE.


What is the valuation status of IDENTIV INC (INVE) stock?

ChartMill assigns a valuation rating of 0 / 10 to IDENTIV INC (INVE). This can be considered as Overvalued.


Can you provide the profitability details for IDENTIV INC?

IDENTIV INC (INVE) has a profitability rating of 1 / 10.


What is the financial health of IDENTIV INC (INVE) stock?

The financial health rating of IDENTIV INC (INVE) is 8 / 10.